Xilio director granted 5,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Xilio Therapeutics director Sara Bonstein received a grant of stock options covering 5,000 shares of common stock. The options have an exercise price of $7.99 per share and expire on June 10, 2036. They vest 100% on June 11, 2027 or at the next annual stockholder meeting, whichever occurs first, assuming continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 5,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option was granted on June 11, 2026 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 11, 2027 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Key Figures
Key Terms
Stock Option (right to buy) financial
Grant, award, or other acquisition financial
exercise price financial
annual meeting of stockholders financial
vesting date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Xilio Therapeutics (XLO) director Sara Bonstein report on this Form 4?
What are the key terms of Sara Bonstein’s Xilio Therapeutics stock options?
When do Sara Bonstein’s Xilio Therapeutics options vest according to this Form 4?
Does this Xilio Therapeutics Form 4 show any stock sales or purchases by Sara Bonstein?
How many Xilio Therapeutics options does Sara Bonstein hold after this grant?
What is the nature of ownership for Sara Bonstein’s Xilio Therapeutics option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.